Article
Emerging Biomarkers in Glioblastoma
22 Aug 2013
Abstract excerpt
Glioblastoma, the most common primary brain tumor, has few available therapies providing significant improvement in survival. Molecular signatures associated with tumor aggressiveness as well as with disease progression and their relation to differences in signaling pathways implicated in gliomagenesis have recently been described. A number of biomarkers which have potential in diagnosis, prognosis and prediction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.